We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$1.67B
Turnover
44.44%
1-Year Est. Return
1.43%
This Fund
S&P 500
This Quarter
Est. Return
+1.91%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
–
AUM
$1.67B
AUM Growth
-$505M
(-23%)
Cap. Flow
-$520M
Cap. Flow
% of AUM
-31.03%
Top 10 Holdings %
Top 10 Hldgs %
29.21%
Holding
171
New
21
Increased
23
Reduced
68
Closed
55
Avg Time Held Equity + Options
1.1
years
Top 10 Avg Time Held Equity + Options
0.6
years
Top 20 Avg Time Held Equity + Options
0.8
years
Avg Time Held Equity only
1.1
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$47.1M |
| 2 |
Becton Dickinson
BDX
|
+$40.9M |
| 3 |
Universal Health Services
UHS
|
+$39.4M |
| 4 |
Intuit
INTU
|
+$37.1M |
| 5 |
SPS Commerce
SPSC
|
+$33.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chord Energy
CHRD
|
+$73.2M |
| 2 |
Teleflex
TFX
|
+$52.2M |
| 3 |
Akamai
AKAM
|
+$46.6M |
| 4 |
RingCentral
RNG
|
+$30.2M |
| 5 |
Haemonetics
HAE
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Healthcare | 19.57% |
| 3 | Industrials | 14.44% |
| 4 | Consumer Discretionary | 10.33% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
monday.com
MNDY
$3.95B
| $21M | 1.26% |
290,707
+90,190
| +45% | +$6.61M |
2026 Q1
1 quarter
|
|
27
Ingredion
INGR
$6.21B
| $20.9M | 1.25% |
220,493
-40,178
| -15% | -$4.25M |
2025 Q4
2 quarters
|
|
28
Upwork
UPWK
$1.08B
| $20.1M | 1.2% |
2,406,922
+492,421
| +26% | +$4.66M |
2025 Q3
3 quarters
|
|
29
Huron Consulting
HURN
$2.84B
| $19.8M | 1.19% |
+220,073
| New | +$25.2M |
2026 Q2
0 quarters
|
|
30
Dole
DOLE
$1.3B
| $19.6M | 1.17% |
1,430,966
-329,343
| -19% | -$4.79M |
2024 Q4
6 quarters
|
|
31
UiPath
PATH
$6.96B
| $19.4M | 1.16% |
1,787,590
+150,688
| +9% | +$1.61M |
2025 Q3
3 quarters
|
|
32
FIVE9
FIVN
$2.53B
| $19M | 1.14% |
892,658
-44,130
| -5% | -$871K |
2025 Q4
2 quarters
|
|
33
dLocal
DLO
$4.38B
| $18.1M | 1.08% |
1,395,170
+1,139,818
| +446% | +$14.5M |
2026 Q1
1 quarter
|
|
34
Progress Software
PRGS
$1.64B
| $17.2M | 1.03% |
+511,240
| New | +$15.1M |
2026 Q2
0 quarters
|
|
35
LegalZoom.com
LZ
$1.07B
| $16.4M | 0.98% |
2,676,821
-247,780
| -8% | -$1.52M |
2025 Q1
5 quarters
|
|
|
36
Haemonetics
HAE
$5.5B
| $16.2M | 0.97% |
216,217
-448,512
| -67% | -$28.8M |
2026 Q1
1 quarter
|
|
37
Enovis
ENOV
$1.1B
| $16M | 0.95% |
772,034
-131,428
| -15% | -$3.1M |
2024 Q4
6 quarters
|
|
38
Tennant Co
TNC
$1.13B
| $16M | 0.95% |
182,387
-167,005
| -48% | -$13.9M |
2024 Q4
6 quarters
|
|
39
Coursera
COUR
$1.35B
| $15.8M | 0.94% |
2,798,362
-752,364
| -21% | -$4.27M |
2024 Q2
8 quarters
|
|
40
PENN Entertainment
PENN
$2.01B
| $15.8M | 0.94% |
738,495
-806,272
| -52% | -$14.4M |
2023 Q3
11 quarters
|
|
41
Comcast
CMCSA
$77.3B
| $15.5M | 0.92% |
629,808
+542,298
| +620% | +$14M |
2025 Q4
2 quarters
|
|
42
Zimmer Biomet
ZBH
$18.1B
| $15.4M | 0.92% |
178,691
+8,985
| +5% | +$788K |
2025 Q4
2 quarters
|
|
43
Gen Digital
GEN
$14.6B
| $15.2M | 0.91% |
610,309
+347,374
| +132% | +$7.76M |
2026 Q1
1 quarter
|
|
44
GE HealthCare
GEHC
$31.9B
| $14.9M | 0.89% |
+233,035
| New | +$15.3M |
2026 Q2
0 quarters
|
|
45
Prudential Financial
PRU
$39.8B
| $14.6M | 0.87% |
135,381
+15,730
| +13% | +$1.6M |
2026 Q1
1 quarter
|
|
46
KBR
KBR
$4.58B
| $12.8M | 0.76% |
+369,476
| New | +$12.9M |
2026 Q2
0 quarters
|
|
47
Ryerson Holding Corp
RYZ
$1.4B
| $12.5M | 0.75% |
508,048
-136,236
| -21% | -$3.6M |
2025 Q3
3 quarters
|
|
48
Chewy
CHWY
$8.64B
| $12.1M | 0.72% |
+613,972
| New | +$13.9M |
2026 Q2
0 quarters
|
|
49
Crane NXT
CXT
$3.07B
| $12M | 0.71% |
233,914
+85,733
| +58% | +$3.66M |
2025 Q4
2 quarters
|
|
50
Medtronic
MDT
$122B
| $11.9M | 0.71% |
+152,330
| New | +$12.3M |
2026 Q2
0 quarters
|
|
Similar funds
IAIM
ACM
CC
CUAMC
SH
ZBNA
DG
KRSITF
Invenomic Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Invenomic Capital Management held 171 positions worth $1.67B, down 23% from $2.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invenomic Capital Management withdrew a net $520M in Q2 2026, closing 55 positions and reducing 68 holdings. Its most notable exit was Chord Energy, an estimated $73.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Invenomic Capital Management opened a new position in Charter Communications worth $40.2M.
- Invenomic Capital Management's largest Q2 2026 buy was Charter Communications: 282,416 shares worth $40.2M.
- Invenomic Capital Management added most to Universal Health Services in Q2 2026, an estimated $39.4M increase.
- Invenomic Capital Management's biggest Q2 2026 reduction was Haemonetics, cutting an estimated $28.8M.
- Invenomic Capital Management fully exited Chord Energy in Q2 2026, selling an estimated $73.2M.
- Invenomic Capital Management's ten largest holdings make up 29% of its $1.67B portfolio in Q2 2026.
- Invenomic Capital Management opened 21 new positions and closed 55 in Q2 2026.
- Invenomic Capital Management's portfolio value fell 23% quarter-over-quarter to $1.67B.
Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.